elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26775011-05527894-91EB-4673-9236-66CE4A0682F0
Q26775011-05527894-91EB-4673-9236-66CE4A0682F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775011-05527894-91EB-4673-9236-66CE4A0682F0
Chronic hepatitis C: This and the new era of treatment
P2860
Q26775011-05527894-91EB-4673-9236-66CE4A0682F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775011-05527894-91EB-4673-9236-66CE4A0682F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
084668326a1b77841dc3005fdd78d169cefc9e12
P2860
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.